Published in J Immunol on July 01, 1989
The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO J (1991) 1.63
Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin. J Exp Med (1995) 1.17
Transcriptional control in keratinocytes and fibroblasts using synthetic ligands. J Clin Invest (1997) 0.82
Regulation of alternative splicing in the generation of isoforms of the mouse Ly-5 (CD45) glycoprotein. Proc Natl Acad Sci U S A (1990) 0.82
Rapid non-radioactive TMACl hybridization protocol employing enzymatically labeled oligonucleotides. Nucleic Acids Res (1991) 0.75
Comparison of blue dye visualization and glucose oxidase test strip methods for detecting pulmonary aspiration of enteral feedings in intubated adults. Chest (1993) 1.76
Brain and thymus lipid inhibition of antibrain-associated theta-cytotoxicity. J Exp Med (1974) 1.06
Modulation of the immune response by antigen-reactive lymphocytes after cultivation with gangliosides. J Immunol (1975) 1.06
Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res (1993) 1.04
Products of linoleic hydroperoxide-decomposing enzyme of alfalfa seed. J Lipid Res (1974) 1.00
Structure of a pentahexosylceramide (Forssman hapten) from canine intestine and kidney. J Biol Chem (1973) 0.93
Poly-N-acetyllactosamine structures on murine cell surface T200 glycoprotein participate in natural killer cell binding to YAC-1 targets. J Immunol (1988) 0.91
Phosphorylation of CD45 by casein kinase 2. Modulation of activity and mutational analysis. J Biol Chem (1999) 0.90
Release of thy-1.2 and thy-1.1 from lymphoblastoid cells: partial characterization and antigenicity of shed material. J Immunol (1978) 0.88
Developmental expression of CD45 alternate exons in murine T cells. Evidence of additional alternate exon use. J Immunol (1991) 0.87
Modulation of B cell responses by glycolipid released from antigen-stimulated T cells. J Immunol (1977) 0.86
LAR-PTPase cDNA transfection suppression of tumor growth of neu oncogene-transformed human breast carcinoma cells. Mol Carcinog (1995) 0.83
Glucose content of tracheal aspirates. Crit Care Med (1995) 0.83
Molecular weight and charge heterogeneity of Thy-1 glycoprotein in different populations of T-cells. Mol Immunol (1984) 0.83
Membrane expression of Thy-1,2 and GM1 ganglioside on differentiating T lymphocytes. J Immunol (1976) 0.82
cAMP potentiates H(2)O(2)-induced ERK1/2 phosphorylation without the requirement for MEK1/2 phosphorylation. Cell Signal (2001) 0.81
Regulation of B cell tolerance by murine gangliosides. Cell Immunol (1982) 0.81
Growth of MCF-7 human breast carcinoma in severe combined immunodeficient mice: growth suppression by recombinant interleukin-2 treatment and role of lymphokine-activated killer cells. Cancer Immunol Immunother (1992) 0.80
Identification of theta-bearing T-cells derived from bone marrow cells treated with thymic factor. Ann N Y Acad Sci (1975) 0.79
Community-acquired pneumonia and infection with respiratory syncytial virus. Ann Intern Med (1988) 0.79
Thy-1 antigenicity is associated with glycolipids of brain and thymocytes. J Immunol (1978) 0.79
Antigen induced modulation by shed lymphocyte membrane gangliosides. Immunol Commun (1980) 0.77
Soluble factors containing Thy-1 antigen shed from lymphoblastoid cells modulate in vitro plaque-forming cell response. J Immunol (1979) 0.77
Poly-N-acetyllactosamine alterations of Thy-1 glycoprotein in lymphocyte differentiation. Mol Immunol (1986) 0.77
Glycosphingolipids of membrane fractions from normal and transplanted canine kidney. J Biol Chem (1973) 0.77
Regulation of the calcium/NF-AT T cell activation pathway by the D2 domain of CD45. J Immunol (2000) 0.76
Adherent lymphokine-activated natural killer cells in normal and severe combined immunodeficiency mice: large granular lymphocytes with natural killer cell phenotype and high cytolytic activity. Nat Immun Cell Growth Regul (1989) 0.76
Protein tyrosine phosphatases: cellular regulators of human breast cancer? Cancer Treat Res (1996) 0.76
Respiratory syncytial virus pneumonia in hospitalized adults. Arch Intern Med (1991) 0.75
Gas--liquid chromatography--mass spectrophotometry of hydroxylated octadecanols derived from hydroxylated stearic acids. J Lipid Res (1969) 0.75
Public's dissatisfaction with medical care a mandate to new and established MDs. Mich Med (1980) 0.75
Expanding the ranks of academic general internal medicine not just any port in a storm. J Gen Intern Med (1988) 0.75
Surface Ly-5 glycoprotein in murine natural killer (NK) cell development, target binding and cytotoxicity. Immunol Invest (1986) 0.75
Coughing and central venous catheter dislodgement. JPEN J Parenter Enteral Nutr (1991) 0.75
Identification of in vivo phosphorylation sites of CD45 protein-tyrosine phosphatase in 70Z/3.12 cells. J Biol Chem (1997) 0.75
The isolation and specificity of alfalfa lipoxygenase. Lipids (1971) 0.75
Elevation of lymphocyte CD45 protein tyrosine phosphatase activity during mitosis. J Immunol (1994) 0.75
Neuraminidase sensitivity of Thy-1 active glycoconjugates. Mol Immunol (1980) 0.75
Interaction of gangliosides with B cells in splenic fragment cultures. Cell Immunol (1984) 0.75
Lineage switch macrophages can present antigen. Dev Immunol (1992) 0.75
Characterization of the CD45 molecule on murine intestinal intraepithelial lymphocytes. J Immunol (1990) 0.75
Detection of Thy-1.2 membrane complexes shed from thymocytes and lymphoma cells by an immunoradiometric assay. Mol Immunol (1980) 0.75
Radiolabeling and isolation of Thy-1 active glycolipids from murine brain and lymphoma cell lines. J Immunol (1979) 0.75